{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:29:24Z","timestamp":1757618964499,"version":"3.44.0"},"reference-count":16,"publisher":"BMJ","issue":"3","funder":[{"name":"Sanofi-Aventis\u00ae GmbH, Berlin, Germany","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2020,8,11]]},"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1136\/ejhpharm-2020-002408","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T17:26:05Z","timestamp":1601918765000},"page":"164-168","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion"],"prefix":"10.1136","volume":"29","author":[{"given":"Andr\u00e9","family":"Mohr","sequence":"first","affiliation":[{"name":"Pharmacy, University Medical Center, Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Kr\u00e4mer","sequence":"additional","affiliation":[{"name":"Pharmacy, University Medical Center, Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,10,5]]},"reference":[{"key":"2025090702311158000_29.3.164.1","unstructured":"Thiamazol Henning\u00ae . Summary of product characteristics updated February-2019: Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany. Available: https:\/\/mein.sanofi.de\/produkte\/Thiamazol\/Downloads?id=f8a5a02b-6b30-4c7e-8882-cd8df1b0c6c0 [Accessed 08 Mar 2020]."},{"key":"2025090702311158000_29.3.164.2","unstructured":"Dear doctor letter: Rote-hand-brief on drugs containing carbimazole or thiamazole: Risk of acute pancreatitis and reinforcement of the recommendation on contraception, 2019. Available: https:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RHB\/2019\/rhb-carbimazol_thiamazol.html"},{"key":"2025090702311158000_29.3.164.3","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.16.691"},{"key":"2025090702311158000_29.3.164.4","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198510050-00006"},{"key":"2025090702311158000_29.3.164.5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1507\/endocrj1954.33.605","article-title":"Pharmacokinetics of methimazole in normal subjects and hyperthyroid patients","volume":"33","author":"Okamura","year":"1986","journal-title":"Endocrinol Jpn"},{"key":"2025090702311158000_29.3.164.6","first-page":"522","article-title":"Stability of methimazole in poloxamer lecithin organogel to determine beyond-use date","volume":"14","author":"Pignato","year":"2010","journal-title":"Int J Pharm Compd"},{"key":"2025090702311158000_29.3.164.7","unstructured":"National Center for Biotechnology Information . Available: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Methimazole [Accessed 16 Sep 2019]."},{"key":"2025090702311158000_29.3.164.8","article-title":"Chromatographic methods development, validation and degradation characterization of the antithyroid drug carbimazole","volume":"4","author":"Abdelrhaman","year":"2018","journal-title":"Biomed Chromatogr"},{"key":"2025090702311158000_29.3.164.9","unstructured":"Council of Europe . European Pharmacopoeia. In: Monography carbimazole 9.0\/0844. 9th edn 9.4, 2019."},{"key":"2025090702311158000_29.3.164.10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0731-7085(97)00119-2","article-title":"Study of the British pharmacopeia method on methimazole (thiamazole) content in carbimazole tablets","volume":"16","author":"Aletrari","year":"1998","journal-title":"J Pharm Biomed Anal"},{"key":"2025090702311158000_29.3.164.11","first-page":"500","article-title":"Determination of thiamazole in human plasma by a rapid HPLC-method","volume":"2","author":"Zhuo","year":"2002","journal-title":"Pharm Care Res"},{"key":"2025090702311158000_29.3.164.12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s11094-019-02039-3","article-title":"Validation of spectrophotometric method for determination of thiamazole in liquids by dissolution test for the transdermal form","volume":"53","author":"Datkhayev","year":"2019","journal-title":"Pharm Chem J"},{"key":"2025090702311158000_29.3.164.13","unstructured":"Thiamazol 40 mg inject Henning\u00ae. Sanofi-Aventis Deutschland GmbH. Data on file 2007."},{"key":"2025090702311158000_29.3.164.14","unstructured":"ICH harmonized tripartite guidelines for validation of analytical procedures: text and methodology Q2 (R1), 1994. Available: https:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q2_R1\/Step4\/Q2_R1__Guideline.pdf [Accessed 08 Mar 2020]."},{"key":"2025090702311158000_29.3.164.15","unstructured":"Council of Europe . European Pharmacopoeia. In: Particle contamination: subvisible particles 9.0\/2.09.19.00. 9th edn 9.4, 2019."},{"key":"2025090702311158000_29.3.164.16","unstructured":"United States Pharmacopeial Convention . The United States pharmacopeia and national formulary. USP 40-NF35, 2017: 5075\u20136."}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2020-002408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:31:18Z","timestamp":1757237478000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2020-002408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,5]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,4,22]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1136\/ejhpharm-2020-002408"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2020-002408","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2020,10,5]]}}}